Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Protocolo MAPT: Tratamientos Quirúrgicos de Fijación versus Artroplastia para la Recuperación Temprana Después de una Fractura de CADERA (FASTER-HIP) (FASTER-HIP)

5 de noviembre de 2026 actualizado por: Joseph Patterson, University of Southern California

Ensayo de Plataforma Adaptativa Musculoesquelética (MAPT): Tratamientos Quirúrgicos de Fijación Versus Artroplastia para una Recuperación Temprana Después de una Fractura de CADERA (FASTER-HIP)

This study is an intervention domain of the Musculoskeletal Adaptive Platform Trial. The primary goal of this pragmatic, randomized, open-label, comparative effectiveness trial is to evaluate if arthroplasty is superior to internal fixation when used to treat minimally displaced femoral neck fractures in older adults ≥60 years old. We hypothesize that arthroplasty will reduce death, preserve ambulation, increase days alive and out of hospital, and improve health status compared to internal fixation within 4 months and 12 months from randomization.

Descripción general del estudio

Descripción detallada

The Musculoskeletal Adaptive Platform Trial (MAPT) is an adaptive platform trial protocol that enables the simultaneous evaluation of multiple interventions (i.e., intervention domains) within a consistent infrastructure. Each intervention being evaluated in the MAPT will have an intervention domain protocol that describes additional eligibility criteria, interventions, secondary outcomes, and statistical stopping rules. The overarching objective of the MAPT trial platform is to incrementally decrease decisional uncertainty and identify treatments that will optimize patient outcomes. The platform focuses on the comparative effectiveness of available treatment options.

Adult patients aged 60 years or older with a low-energy minimally displaced femoral neck fracture treated with surgery are eligible for the FASTER-HIP intervention domain. Nearly half of all elderly hip fractures are femoral neck fractures, and approximately 20% are minimally displaced. Internal fixation has remained the treatment of choice for these injuries because these fractures can be fixed in situ, and the surgical implants can be inserted with little surgical dissection. Patients treated with internal fixation experience high complication rates, with the pooled risk of reoperation and mortality each above 14%. Preliminary data have suggested arthroplasty for minimally displaced fractures may lead to better patient outcomes, including improved ambulation, fewer reoperations, and a lower risk of death compared to internal fixation. While the preliminary data supporting the use of arthroplasty for minimally displaced fractures is promising, the necessary evidence to make this practice change remains lacking.

FASTER-HIP is a pragmatic, randomized, open-label, comparative effectiveness trial comparing hip arthroplasty versus internal fixation for minimally displaced femoral neck fractures. Randomization in this domain occurs in a 1:1 ratio (hip arthroplasty:internal fixation). The primary outcome is a composite of death within 120 days, ambulation status at 120 days, and days alive and out of hospital within 120 days of randomization. The primary outcome will be hierarchically assessed using the Win ratio. Secondary outcomes include the same composite at 365 days, individual components of the composite, health-related quality of life (EQ-5D-5L), and pain scores during hospitalization.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

600

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

      • Ottawa, Canadá, K1H 8L6
        • Aún no reclutando
        • The Ottawa Hospital
        • Contacto:
        • Investigador principal:
          • Bradley Meulenkamp, MD
    • British Columbia
      • Vancouver, British Columbia, Canadá, V6T 1Z4
        • Reclutamiento
        • University of British Columbia
        • Contacto:
          • Aresh Sepehri, MD
        • Contacto:
        • Investigador principal:
          • Aresh Sephri, MD
      • Vancouver, British Columbia, Canadá
        • Reclutamiento
        • Fraser Health Authority
        • Contacto:
        • Contacto:
          • Número de teléfono: 604-777-5577
        • Investigador principal:
          • Darius Viskontas, MD
    • Ontario
      • London, Ontario, Canadá, N6A 5W9,
        • Reclutamiento
        • London Health Sciences Centre
        • Contacto:
        • Investigador principal:
          • Emil Schemitsch, MD
      • Barcelona, España
        • Aún no reclutando
        • Hospital Universitari Vall d'Hebron
        • Contacto:
        • Investigador principal:
          • Carlos Alberto Piedra-Calle, MD
      • Barcelona, España
        • Aún no reclutando
        • Consorci Sanitari de l'Alt Penedès i Garraf (CSAPG)
        • Investigador principal:
          • Alfred Dealbert, MD
        • Contacto:
      • Barcelona, España, 08221
        • Aún no reclutando
        • Hospital Universitario Mutua de Terrassa
        • Contacto:
        • Investigador principal:
          • Pablo Castillon Bernal, MD
      • Barcelona, España
        • Aún no reclutando
        • FRCB-IDIBAPS (Hospital Clinic Barcelona)
        • Contacto:
        • Investigador principal:
          • Pilar Camacho, MD
    • California
      • Irvine, California, Estados Unidos, 92660
        • Reclutamiento
        • University of California, Irvine
        • Investigador principal:
          • Gerard Slobogean, MD
        • Contacto:
          • Gerard Slobogean, MD
          • Número de teléfono: 714-456-1699
          • Correo electrónico: gsloboge@hs.uci.edu
      • Los Angeles, California, Estados Unidos, 90048
        • Reclutamiento
        • Cedars-Sinai Medical Center
        • Investigador principal:
          • Carol Lin, MD
        • Contacto:
      • Los Angeles, California, Estados Unidos, 90033
        • Reclutamiento
        • University of Southern California
        • Investigador principal:
          • Joshua L Gary, MD
        • Contacto:
      • Los Angeles, California, Estados Unidos, 90033
        • Reclutamiento
        • Los Angeles General Medical Center
        • Investigador principal:
          • Joshua L Gary, MD
        • Contacto:
      • San Francisco, California, Estados Unidos, 94143
        • Reclutamiento
        • University of California San Francisco
        • Investigador principal:
          • Saam Morshed, MD
        • Contacto:
    • Florida
      • Miami, Florida, Estados Unidos, 33146
        • Aún no reclutando
        • University of Miami
        • Contacto:
        • Investigador principal:
          • Giselle Hernandez, MD
    • Indiana
      • Bloomington, Indiana, Estados Unidos, 47405
        • Reclutamiento
        • Indiana University
        • Investigador principal:
          • Dillon O'Neill, MD
        • Contacto:
    • Maryland
      • Baltimore, Maryland, Estados Unidos, 21201
        • Reclutamiento
        • University of Maryland, Baltimore - R Adams Cowley Shock Trauma Center
        • Investigador principal:
          • Mark Gage, MD
        • Contacto:
      • Largo, Maryland, Estados Unidos, 20774
        • Reclutamiento
        • University of Maryland Capital Region Health
        • Investigador principal:
          • Todd Jaeblon, MD
        • Contacto:
    • Massachusetts
      • Boston, Massachusetts, Estados Unidos, 02215
        • Aún no reclutando
        • Beth Israel Deaconess Medical Center
        • Contacto:
        • Investigador principal:
          • Ishaq Ibrahim, MD
      • Boston, Massachusetts, Estados Unidos, 02115
        • Reclutamiento
        • Massachusetts General Brigham
        • Contacto:
        • Investigador principal:
          • Michael Weaver, MD
    • Mississippi
      • University, Mississippi, Estados Unidos, 38677
        • Reclutamiento
        • University of Mississippi
        • Investigador principal:
          • Patrick Bergin, MD
        • Contacto:
    • New York
      • New York, New York, Estados Unidos, 10016
        • Reclutamiento
        • NYU Langone Health
        • Investigador principal:
          • Ran Schwarzkopf, MD
        • Contacto:
    • Ohio
      • Cincinnati, Ohio, Estados Unidos, 45221
        • Reclutamiento
        • University of Cincinnati
        • Contacto:
        • Investigador principal:
          • Michael Beltran, MD
    • Oklahoma
      • Oklahoma City, Oklahoma, Estados Unidos, 73104
        • Reclutamiento
        • University of Oklahoma Health Sciences Center
        • Investigador principal:
          • Brandon Hull, MD
        • Contacto:
    • Pennsylvania
      • Allentown, Pennsylvania, Estados Unidos, 18102
        • Reclutamiento
        • St. Luke's University Health System
        • Investigador principal:
          • Dustin Greenhill, MD
        • Contacto:
    • South Carolina
      • Greenville, South Carolina, Estados Unidos, 29601
        • Reclutamiento
        • Prisma Health-Upstate
        • Investigador principal:
          • Kyle Jeray, MD
        • Contacto:
    • Tennessee
      • Nashville, Tennessee, Estados Unidos, 37235
        • Reclutamiento
        • Vanderbilt University
        • Contacto:
        • Investigador principal:
          • Lauren Tatman, MD
    • Utah
      • Salt Lake City, Utah, Estados Unidos, 84108
        • Reclutamiento
        • University of Utah
        • Investigador principal:
          • Lucas Marchand, MD
        • Contacto:
    • Vermont
      • Burlington, Vermont, Estados Unidos, 05405
        • Aún no reclutando
        • University of Vermont
        • Contacto:
        • Investigador principal:
          • Michael Blankstein, MD
    • Virginia
      • Fairfax, Virginia, Estados Unidos, 22031
        • Reclutamiento
        • Inova Health Care Services
        • Investigador principal:
          • Greg Gaski, MD
        • Contacto:
    • Wisconsin
      • Madison, Wisconsin, Estados Unidos, 53706
        • Reclutamiento
        • University of Wisconsin - Madison
        • Investigador principal:
          • Chris Domes, MD
        • Contacto:
      • Grålum, Noruega, 1714
        • Reclutamiento
        • Sykehuset Østfold HF / Østfold Hospital Trust
        • Contacto:
          • Frede Frihagen, MD
        • Contacto:
        • Investigador principal:
          • Frede Frihagen, MD
      • Edinburgh, Reino Unido, EH8 8BG

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

60 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • 60 years of age or older undergoing surgery due to a minimally displaced femoral neck fracture
  • The patient has a health condition affecting physical mobility.
  • Complete fracture of the femoral neck (AO/OTA 31B) confirmed with anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging.
  • Minimally displaced fracture that could be, in the judgment of the attending surgeon, managed with either arthroplasty or in situ internal fixation without reduction.
  • Low energy injury mechanism.
  • Surgeons with expertise in internal fixation and total hip arthroplasty or hemiarthroplasty are available to perform surgery.

Exclusion Criteria:

  • The patient is not clinically suitable for either compared treatment.
  • Expected injury survival of less than 12 months.
  • Terminal illness with expected survival of less than 12 months.
  • Incarceration.
  • Unable to obtain informed consent due to language barriers.
  • Unable to obtain informed consent because the legally authorized representative was unavailable.
  • Problems, in the judgment of the study personnel, with maintaining follow-up with the patient.
  • Currently enrolled in a study or intervention domain that does not permit co-enrollment.
  • Prior enrollment in the specific platform trial intervention domain.
  • Patient or legally authorized representative did not provide informed consent (declined participation).
  • Eligible patient or legally authorized representative was not approached within the screening window (missed participant).
  • Other reasons to exclude the patient, as approved by the data coordinating center.
  • Associated lower extremity injury that prevents post-operative weight-bearing.
  • Retained hardware around the hip that precludes either study treatment.
  • Infection around the hip (soft tissue or bone).
  • Pathologic fracture with a lytic lesion in the femoral neck that precludes internal fixation.
  • Injury did not occur within 21 days of screening.
  • Patient is too ill, in the judgment of the attending surgeon, for internal fixation.
  • Patient is too ill, in the judgment of the attending surgeon, for arthroplasty.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: Artroplastia de cadera

Participants will undergo surgical treatment using standard hip arthroplasty techniques for femoral minimally displaced femoral neck fracture. A modern porous-coated press-fit or cemented hip arthroplasty prosthesis will be used at the treating surgeon's discretion. Press-fit implants that have no ingrowth or ongrowth surface will not be permitted. The type of hip prosthesis (hemiarthroplasty or total hip arthroplasty), bearing (single or dual mobility), or the method of arthroplasty fixation (cemented or uncemented) will be at the discretion of the treating surgeon.

Comparador activo: Fijación interna

Participants will undergo surgical treatment using standard fixation techniques for minimally displaced femoral neck fractures. The treating surgeon may perform fracture reduction maneuvers if desired. Fixed-angle devices and multiple screws will be permitted. The internal fixation device(s) will be inserted through a small lateral incision. Internal fixation constructs combining cancellous screws and fixed-angle devices will be permitted.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Composite outcome of death, ambulation status, and days alive and out of hospital.
Periodo de tiempo: 120 days after randomization

Death consists of time to all-cause mortality.

Ambulation will be evaluated using an ordinal ranking of independence.

Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:

  • Days not alive.
  • Any day on which the participant had an overnight stay in a hospital, inpatient rehabilitation, skilled nursing facility, nursing home, inpatient mental health care facility, or long-term care facility.
120 days after randomization

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Composite outcome of death, ambulation status, and days alive and out of hospital.
Periodo de tiempo: 365 days after randomization

Death consists of time to all-cause mortality.

Ambulation will be evaluated using an ordinal ranking of independence.

Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:

  • Days not alive.
  • Any day on which the participant had an overnight stay in a hospital, inpatient rehabilitation, skilled nursing facility, nursing home, inpatient mental health care facility, or long-term care facility.
365 days after randomization
Death
Periodo de tiempo: 120 days post-randomization

Death consists of time to all-cause mortality.

120 days post-randomization
Death
Periodo de tiempo: 12 months post-randomization

Death consists of time to all-cause mortality.

12 months post-randomization
Ambulation status
Periodo de tiempo: 120 days post-randomization

Ambulation will be evaluated using an ordinal ranking of independence

120 days post-randomization
Ambulation status
Periodo de tiempo: 12 months post-randomization

Ambulation will be evaluated using an ordinal ranking of independence

12 months post-randomization
Days alive and out of hospital
Periodo de tiempo: 120 days post-randomization

Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:

  • Days not alive.
  • Any day on which the participant had an overnight stay in a hospital, inpatient rehabilitation, skilled nursing facility, nursing home, inpatient mental health care facility, or long-term care facility.
120 days post-randomization
Days alive and out of hospital
Periodo de tiempo: 12 months post-randomization

Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:

  • Days not alive.
  • Any day on which the participant had an overnight stay in a hospital, inpatient rehabilitation, skilled nursing facility, nursing home, inpatient mental health care facility, or long-term care facility.
12 months post-randomization
Health-related quality of life
Periodo de tiempo: 120 days days post-randomization

EQ-5D-5L - Range: 0 to 1, Higher scores indicates better self-perceived health

120 days days post-randomization
Health-related quality of life
Periodo de tiempo: 12 months post-randomization

EQ-5D-5L - Range: 0 to 1, Higher scores indicates better self-perceived health

12 months post-randomization
Numeric Pain Rating Scale
Periodo de tiempo: During hospitalization in the first seven postoperative days

The highest level of pain recorded daily in the participant's medical record - Range: 0-10, higher score indicates higher level of pain

During hospitalization in the first seven postoperative days

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Joseph T Patterson, MD, University of Southern California

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

23 de enero de 2026

Finalización primaria (Estimado)

28 de febrero de 2029

Finalización del estudio (Estimado)

31 de enero de 2030

Fechas de registro del estudio

Enviado por primera vez

31 de octubre de 2025

Primero enviado que cumplió con los criterios de control de calidad

19 de noviembre de 2025

Publicado por primera vez (Actual)

24 de noviembre de 2025

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

10 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

5 de noviembre de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir